Table 10.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1997 to 2006

Recipients with Intestine Transplants

  Transplant Year
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Functioning Graft at Discharge 45 47 49 61 88 89 103 130 153 148
With Immunosuppression Info 44 47 49 61 88 89 103 127 150 148
--- + MMF/MPA 0.0% 0.0% 0.0% 1.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + MMF/MPA + Steroids 0.0% 2.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.7% 0.7%
--- + OtherAntimet + Steroids 0.0% 0.0% 0.0% 1.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + Siro/Evero + Steroids 0.0% 0.0% 0.0% 1.6% 1.1% 0.0% 0.0% 1.6% 0.7% 0.0%
--- + Steroids 2.3% 0.0% 0.0% 0.0% 1.1% 2.2% 3.9% 0.8% 2.0% 1.4%
CyA + Steroids 2.3% 6.4% 4.1% 0.0% 0.0% 0.0% 1.0% 0.0% 0.0% 0.0%
Tac 0.0% 0.0% 4.1% 1.6% 18.2% 31.5% 30.1% 22.8% 26.0% 16.9%
Tac + MMF/MPA 2.3% 0.0% 2.0% 0.0% 0.0% 1.1% 0.0% 0.0% 0.7% 7.4%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 0.0% 0.0% 0.0%
Tac + MMF/MPA + Steroids 34.1% 27.7% 14.3% 13.1% 3.4% 7.9% 6.8% 8.7% 10.0% 9.5%
Tac + OtherAntimet + Steroids 9.1% 2.1% 6.1% 0.0% 6.8% 0.0% 0.0% 0.0% 0.0% 0.7%
Tac + Siro/Evero 0.0% 0.0% 0.0% 0.0% 2.3% 0.0% 0.0% 2.4% 2.0% 2.0%
Tac + Siro/Evero + Steroids 0.0% 0.0% 0.0% 34.4% 18.2% 15.7% 3.9% 7.9% 10.0% 7.4%
Tac + Steroids 43.2% 55.3% 67.3% 41.0% 48.9% 36.0% 50.5% 55.9% 48.0% 53.4%
Other Regimen 6.8% 6.4% 2.0% 4.9% 0.0% 5.6% 2.9% 0.0% 0.0% 0.7%


Source: OPTN/SRTR Data as of May 1, 2007.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.